The aim of this work was to study the delayed effects of chronic neonatal administration of the selective serotonin reuptake inhibitor fluvoxamine (FA) to white rat pups and to estimate the possibility to correct these effects by treatment with semax. Fluvoxamine was injected intraperitoneally at a dose of 10 mg/kg from postnatal days 1 to 14, and semax was injected intranasally at a dose of 0.05 mg/kg from postnatal days 15 to 28. It was shown that neonatal FA administration produced a significant delay in animal somatic growth. A loss in body weight was detected both during FA administration and 4-6 weeks after the last injection. Furthermore, FA administration increased the anxiety level and disturbed the learning ability of animals. The negative consequences of neonatal FA administration were largely compensated by Semax.
Adrenocorticotropic Hormone/analogs & derivatives , Anxiety/drug therapy , Behavior, Animal/drug effects , Learning/drug effects , Peptide Fragments/administration & dosage , Adrenocorticotropic Hormone/administration & dosage , Animals , Anxiety/pathology , Female , Fluvoxamine/toxicity , Male , Rats , Selective Serotonin Reuptake Inhibitors/toxicity
